Product Name | MF | CAS | Details |
---|
(S)-3-(4-bromothiazol-2-yl)-2-((tert-butoxycarbonyl)amino)propanoic acid | C11H15BrN2O4S | 2641451-74-1 | Details |
4,4'-di(pyrrolidin-1-yl)-2,2'-bipyridine | C18H22N4 | 874758-86-8 | Details |
5-Benzothiazolol,2-amino-(9CI) | C7H6N2OS | 118526-19-5 | Details |
17b-(tert-Butylcarbamoyl)-4-aza-5a-androsten-3-one | C23H36N2O2 | 166896-74-8 | Details |
Axitinib Impurity A | C15H13N3OS | 944835-85-2 | Details |
(6S,9R)-6-(2,3-Difluorophenyl)-6,7,8,9-tetrahydro-9-[[tris(1-methylethyl)silyl]oxy]-5H-cyclohepta[b]pyridin-5-one | C25H33F2NO2Si | 1190363-46-2 | Details |
FGF-401 | C25H30N8O4 | 1708971-55-4 | Details |
Trilaciclib Dihydrochloride | C24H31ClN8O | 1977495-97-8 | Details |
FMOC-Ala-OH | C18H17NO4 | 35661-39-3 | Details |
Fulvestrant | C32H47F5O3S | 129453-61-8 | Details |
7H-Pyrrolo[2,3-d]pyrimidin-4-amine, N-methyl-N-[(3R,4R)-4-methyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-3-piperidinyl]- | C19H22N8 | 2504210-38-0 | Details |
2-(2,6-dioxopiperidin-3-yl)-5-(4-(piperidin-4-ylmethyl)piperazin-1-yl)isoindoline-1,3-dione | C23H29N5O4 | 2229725-28-2 | Details |
RMC6291 | C55H78FN9O8 | 2641998-63-0 | Details |
(S)-1-(5-bromo-6-(1-methoxyethyl)pyridin-3-yl)-4-methylpiperazine | 2940879-42-3 | Details |
6-(4-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)piperazin-1-yl)nicotinic acid | 2633591-27-0 | Details |
Ondansetron EP Impurity B | C37H38N6O2 | 1076198-52-1 | Details |
METHYL 2-AMINO-5-CYANOBENZOATE | C9H8N2O2 | 159847-81-1 | Details |
ACT-132577 | C16H14Br2N6O4S | 1103522-45-7 | Details |
(17β)-N-[2,5-Bis(trifluoroMethyl)phenyl]-3-oxo-4-azaandrost-5-ene-17-carboxaMide | C27H30F6N2O2 | 164656-21-7 | Details |
6-Bromo-8-fluoro-3,4-dihydroisoquinolin-1(2H)-one | C9H7BrFNO | 1242157-15-8 | Details |
2'-(Methylthio)-7',8'-dihydro-6'H-spiro[cyclohexane-1,9'-pyrazino[1',2':1,5]pyrrolo[2,3-d]pyrimidin]-6'-one | C15H18N4OS | 2170747-00-7 | Details |
Phenyltrimethylammonium bromide | C9H14BrN | 16056-11-4 | Details |
3-(5-bromo-1H-indol-3-yl)-2,2-dimethylpropan-1-ol | C13H16BrNO | 2641451-60-5 | Details |
1H-Indole, 5-bromo-3-[3-[[(1,1-dimethylethyl)diphenylsilyl]oxy]-2,2-dimethylpropyl]-2-iodo- | C29H33BrINOSi | 2641451-43-4 | Details |
3-((3-aminophenyl)amino)piperidine-2,6-dione | C11H13N3O2 | 1472731-41-1 | Details |
RMC6236 | C44H58N8O5S | 2765081-21-6 | Details |
2-amino-1,3-benzothiazol-7-ol | C7H6N2OS | 62715-76-8 | Details |
tert-butyl 4-(2-(1-methyl-2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)piperazine-1-carboxylate | 2782051-07-2 | Details |
2,8-DIAZA-SPIRO[4.5]DECANE-8-CARBOXYLIC ACID TERT-BUTYL ESTER | C13H24N2O2 | 236406-39-6 | Details |
3,5-Dimethoxyaniline | C8H11NO2 | 10272-07-8 | Details |
(R)-tetrahydro-2H-pyran-3-aMine hydrochloride | C5H11NO | 1071829-82-7 | Details |
6,7,8,9-Dehydro Paliperidone Hydrochloride | C23H23FN4O3 | 170359-61-2 | Details |
2,5-dichlorobenzyl alcohol | C7H6Cl2O | 34145-05-6 | Details |
2-(dimethoxymethyl)-5,6,7,8-tetrahydro-1,8-naphthyridine-3-carbaldehyde | C12H16N2O3 | 1708974-56-4 | Details |
Axitinib amide Impurity | C21H16N4OS | 319462-41-4 | Details |
Fulvestrant EP Impurity F (6-keto-fulvestrant) | C32H45F5O4S | 2858589-78-1 | Details |
(S)-4-(5-bromo-6-(1-methoxyethyl)pyridin-3-yl)morpholine | C12H17BrN2O2 | 3022873-53-3 | Details |
L-Alanine benzyl ester hydrochloride | C10H14ClNO2 | 5557-83-5 | Details |
vortioxetine Impurity E | C17H20N2S | 1293489-71-0 | Details |
N-Boc-1,2,5,6-tetrahydropyridine-4-boronic acid pinacol este | C16H28BNO4 | 286961-14-6 | Details |
3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-9-hydroxy-2-methylpyrido[1,2-a]pyrimidin-4-one | C23H23FN4O3 | 766485-15-8 | Details |
Ondansetron Impurity A | C16H20N2O | 153139-56-1 | Details |
Vinpocetine | C22H26N2O2 | 42971-09-5 | Details |
3-((3R,4R)-3-(7H-[4,7'-bipyrrolo[2,3-d]pyrimidin]-4'-yl(methyl) amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile | C22H23N9O | 2504210-48-2 | Details |
Urea, N-[3-chloro-4-[2-[2-(methylamino)ethoxy]ethyl]phenyl]-N'-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1-oxo-1H-isoindol-5-yl]methyl]- | C26H30ClN5O5 | 2722698-03-3 | Details |
1H-Benzimidazol-4-amine, 5-bromo-1,2-dimethyl-6-(trifluoromethyl)- | C10H9BrF3N3 | 2858644-42-3 | Details |
tert-butyl 6-oxo-3,6-dihydropyridine-1(2H)-carboxylate | C10H15NO3 | 128372-89-4 | Details |
Fludarabine Impurity2 | C11H15N5O5 | 51742-84-8 | Details |
1-(4-bromo-3-chlorophenyl)piperazine | C10H12BrClN2 | 944690-86-2 | Details |
2'-(Methylsulfonyl)-7',8'-dihydro-6'H-spiro[cyclohexane-1,9'-pyrazino[1',2':1,5]pyrrolo[2,3-d]pyrimidin]-6'-one | C15H18N4O3S | 2170747-01-8 | Details |
3-(piperazin-1-yl)benzo[d]isothiazole 1,1-dioxide hydrochloride | C11H14ClN3O2S | 131779-59-4 | Details |
4-hydroxy-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide | C8H11NO5S3 | 120279-26-7 | Details |
6-bromo-1-isopropyl-2-methyl-1H-benzo[d]imidazole | C11H13BrN2 | 1038408-36-4 | Details |
L-Alanine Isopropyl Ester Hydrochloride | C6H13NO2 | 39825-33-7 | Details |
P-hydroxyphenylethanol | C8H10O2 | 501-94-0 | Details |
2-AMino-6-broMo-5,6-dihydro-7(4H)-benzothiazolone | C7H7BrN2OS | 1001648-73-2 | Details |
2-(1-(ethylsulfonyl)-3-(4-(7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile | C22H31N7O3SSi | 1187594-13-3 | Details |
Abiraterone Clopenthixol | C34H49NO2 | 2486052-18-8 | Details |
Benzeneacetamide, 3-ethoxy-4-hydroxy-N-[3-methyl-1-[2-(1-piperidinyl)phenyl]butyl]- | C26H36N2O3 | 2375485-04-2 | Details |
Ethyl 6-bromoimidazo[1,5-a]pyrazine-1-carboxylate | C9H8BrN3O2 | 2803472-83-3 | Details |
Axitinib Impurity B | C15H12IN3OS | 885126-34-1 | Details |
Vortioxetine Impurity D | C19H22N2OS | 2135576-73-5 | Details |
Vortioxetine impurity | C18H22N2S | 1815608-51-5 | Details |
(4-(1-(3-(cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate | C22H27N7O4S | 1187595-90-9 | Details |
2-(2,6-dioxopiperidin-3-yl)-5-(4-(2-(piperidin-4-yl)ethyl)piperazin-1-yl)isoindoline-1,3-dione | C24H31N5O4 | 2460248-35-3 | Details |
2,5-Dichlorobenzoic acid | C7H4Cl2O2 | 50-79-3 | Details |
isoindoline-5-carboxylic acid hydrochloride | C9H10ClNO2 | 149353-72-0 | Details |
(7a,17b)-7-(9-Bromononyl)-estra-1,3,5(10)-triene-3,17-diol-17-acetate | C29H43BrO3 | 875573-66-3 | Details |
N6-Furfuryl-2-aminoadenosine | C15H18N6O5 | 26783-39-1 | Details |
(S)-6-methyl-4-oxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide | C8H9NO3S3 | 1383784-43-7 | Details |
GSK6853 | C22H27N5O3 | 1910124-24-1 | Details |
Trilaciclib | C24H30N8O | 1374743-00-6 | Details |
Vincamine | C21H26N2O3 | 1617-90-9 | Details |
6-Chloro-5-fluoroindole | C8H5ClFN | 122509-72-2 | Details |
4-AMINO-PIPERIDINE-1,4-DICARBOXYLIC ACID 1-TERT-BUTYL ESTER 4-METHYL ESTER | C12H22N2O4 | 321997-89-1 | Details |
3,5-Dihydroxybenzoic acid | C7H6O4 | 99-10-5 | Details |
(R)-3-AMINOTETRAHYDROFURAN | C4H9NO | 111769-26-7 | Details |
2-N-BOC-AMINOMETHYLMORPHOLINE | C10H20N2O3 | 173341-02-1 | Details |
CRBN1 | C20H17ClN2O4 | 1323404-58-5 | Details |
2-AMINOMETHYL-4-BOC-MORPHOLINE | C10H20N2O3 | 140645-53-0 | Details |
Ondansetron EP Impurity G | C17H17N3O | 99614-03-6 | Details |
Zuranolone | C25H35N3O2 | 1632051-40-1 | Details |
Fisetin | C15H10O6 | 528-48-3 | Details |
Vonoprazan N-methylaspartic acid Impurity | C21H20FN3O6S | 2170020-79-6 | Details |
3-(5-bromo-1H-indol-3-yl)-2,2-dimethylpropyl acetate | C15H18BrNO2 | 2641451-61-6 | Details |
2-Thiazolepropanoic acid, 4-bromo-α-[[(1,1-dimethylethoxy)carbonyl]amino]-, methyl ester, (αS)- | C12H17BrN2O4S | 2641451-73-0 | Details |
(S)-Tetrahydro-2H-pyran-3-amine hydrochloride | C5H11NO | 1071829-81-6 | Details |
Vortioxetine Impurity C | C17H20N2S | 508233-82-7 | Details |
5,6,7,8-TETRAHYDROQUINOLINONE-5 | C9H9NO | 53400-41-2 | Details |
1-(4-bromo-3-chlorophenyl)piperazine | C10H12BrClN2 | 1504452-07-6 | Details |
Fulvestrant EP Impurity C | C41H65F5O4S2 | 2482852-42-4 | Details |
(S)-1-(5-bromo-6-(1-methoxyethyl)pyridin-3-yl)-4-cyclopropylpiperazine | Details |
(S)-3-bromo-2-(1-methoxyethyl)pyridine | C8H9BrINO | 2641451-76-3 | Details |
5(6H)-Quinolinone, 2-(aminomethyl)-7,8-dihydro- | C10H12N2O | 1432792-75-0 | Details |
5-bromo-1,2-dimethyl-6-(trifluoromethyl)-1H-benzo[d]imidazole | C10H8BrF3N2 | 2641795-11-9 | Details |
benzyl 4-[5-bromo-6-[(1S)-1-methoxyethyl]-3-pyridyl]piperazine-1-carboxylate | C20H24BrN3O3 | 2641451-78-5 | Details |
3-(5-(2-aminoethyl)-1-oxoisoindolin-2-yl)piperidine-2,6-dione | 2694722-60-4 | Details |
CRBN | C25H26ClN3O5 | 1323402-46-5 | Details |
1-(2-chloro-4-(piperazin-1-yl)phenyl)ethan-1-one | C12H15ClN2O | 909418-69-5 | Details |
Product Total: Product Page: | ||||
1 2 3 |